Chronic Psychiatric
Disease Management
A longitudinal approach to maintenance pharmacotherapy, monitoring, and relapse prevention in chronic mental illness.
What Is Chronic Management?
Chronic psychiatric disease management is the long-term, outpatient stewardship of conditions like major depressive disorder, bipolar disorder, and schizophrenia. Step 3 emphasizes the continuity-of-care phase, not just acute stabilization.
The Three Treatment Phases
The Adherence Problem
Up to 50% of psychiatric patients are non-adherent to maintenance medication. Adherence is the single largest modifiable driver of relapse.
Core Rule: Continue What Worked
Deciding Treatment Duration
For MDD, the recommended maintenance length increases with the number of prior episodes. A useful framing:
Relapse vs. Side Effect
A returning symptom is not always relapse. Distinguish a true return of illness from a medication adverse effect or withdrawal.
A Step-by-Step Approach
Drug-Specific Monitoring
Chronic agents require scheduled labs. Memorize these high-yield pairings:
Lithium's Narrow Therapeutic Window
Worked Example: MDD Maintenance
A 34-year-old woman with her first episode of MDD has been in remission for 4 weeks on sertraline 100 mg. She asks how long to continue.
Worked Example: Bipolar Stability
A 45-year-old man with bipolar I has been stable on lithium for 2 years. Routine labs show TSH 9.0 and a level of \(0.9 \, \text{mEq/L}\).
Worked Example: Worsening Psychosis
A 28-year-old with schizophrenia, stable on risperidone, returns with returning auditory hallucinations. He admits to missing doses for two weeks.
Common Mistakes
Monitoring Summary
| Key Monitoring | Maintenance Note | |
|---|---|---|
| Lithium | Level, TSH, renal | Avoid NSAIDs, thiazides |
| Valproate | Level, LFTs, CBC | Teratogenic; avoid pregnancy |
| Atypical antipsychotic | Glucose, lipids, weight | Metabolic syndrome risk |
| SSRI (MDD) | Mood, suicidality | Continue effective dose |
Question 1 of 5
A 30-year-old woman with a first episode of MDD reaches remission on fluoxetine 20 mg. What is the best maintenance plan?
Question 2 of 5
A bipolar patient on long-term lithium develops fatigue. Labs: TSH 11, lithium level \(0.8 \, \text{mEq/L}\). Best next step?
Question 3 of 5
A patient with three prior episodes of MDD is now in remission. Recommended maintenance duration?
Question 4 of 5
A schizophrenia patient stable on risperidone develops returning hallucinations after admitting to missed doses. Best management?
Question 5 of 5
Which medication change most increases the risk of lithium toxicity in a stable patient?